XML 76 R40.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Components of Loss Before Income Taxes
The components of loss from continuing operations before income taxes are presented below:
Year Ended December 31,
202220212020
Domestic$(76,572)$(107,582)$(97,982)
Foreign(3,394)(3,385)(6,542)
Loss from continuing operations before income taxes$(79,966)$(110,967)$(104,524)
Components of Income Tax Benefit
The components of income tax benefit from continuing operations are presented below:
Year Ended December 31,
202220212020
United States federal income taxes:
Deferred$37 $37 $37 
Foreign income taxes:
Current(39)74 
Deferred(198)(215)(204)
State income taxes:
Deferred11 11 11 
Income tax benefit from continuing operations$(189)$(160)$(82)
Schedule of Effective Income Tax Rate Reconciliation
Income tax benefit from continuing operations for the years ended December 31, 2022, 2021, and 2020 differed from amounts computed by applying the applicable United States federal corporate income tax rate of 21% to loss before income taxes as a result of the following:
202220212020
Computed statutory income tax benefit from continuing operations$(16,793)$(23,303)$(21,950)
State and provincial income tax benefit, net of federal income taxes(2,884)(4,670)(5,199)
Nondeductible stock based compensation179 832 5,709 
Nondeductible officer compensation263 1,459 728 
Impairment of goodwill101 — — 
Nondeductible equity investment loss3,093 — — 
Research and development tax incentives(991)(958)(524)
Acquisition and internal restructuring transaction costs— — — 
United States-foreign rate differential18 (32)(21)
Other, net533 (46)(306)
(16,481)(26,718)(21,563)
Change in valuation allowance for deferred tax assets16,292 26,558 21,481 
Total income tax benefit from continuing operations$(189)$(160)$(82)
Schedule of Deferred Tax Assets and Liabilities
The tax effects of temporary differences that comprise the deferred tax assets and liabilities included in continuing operations as of December 31, 2022 and 2021, are as follows:
20222021
Deferred tax assets
Allowance for doubtful accounts$53 $1,506 
Inventory— 370 
Equity securities and investments in affiliates258 570 
Property, plant and equipment284 — 
Intangible assets69,807 80,540 
Accrued liabilities3,219 3,090 
Lease liabilities2,182 2,839 
Stock-based compensation17,106 15,227 
Deferred revenue474 7,300 
Capitalized research and development cost16,318 — 
Research and development tax credits12,160 11,168 
Net operating, capital loss, and interest expense carryforwards288,397 301,791 
Total deferred tax assets410,258 424,401 
Less: (Valuation allowance)401,086 408,396 
Net deferred tax assets9,172 16,005 
Deferred tax liabilities
Property, plant and equipment— 250 
Right-of-use assets2,071 2,735 
Foreign intangible asset9,364 10,861 
Long-term debt— 4,698 
Total deferred tax liabilities11,435 18,544 
Net deferred tax liabilities included in continuing operations$(2,263)$(2,539)
Summary of Valuation Allowance
Activity within the valuation allowance for deferred tax assets included in continuing operations during the years ended December 31, 2022, 2021, and 2020 was as follows:
202220212020
Valuation allowance at beginning of year$408,396 $387,348 $349,008 
Increase (decrease) in valuation allowance as a result of
Deconsolidation of AquaBounty— — — 
Establishment of deferred taxes for subsidiaries included in discontinued operations— — — 
Current year continuing operations16,292 26,558 21,481 
Discontinued operations treated as asset sales(27,909)(3,626)7,805 
Discontinued operations related to MBP Titan— (1,186)8,019 
Adoption of ASU 2020-064,698 — — 
Foreign currency translation adjustment(391)(698)1,035 
Valuation allowance at end of year$401,086 $408,396 $387,348